Navigation Links
Mayo Clinic moves small-molecule drugs through blood-brain barrier
Date:6/4/2014

ROCHESTER, Minn. Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. The findings appear in PLOS ONE.

"Not only have we shown that we can transport eight different molecules, we think this method will be less disruptive or invasive because it mimics a normal physiological process," says Mayo Clinic neuroscientist Gobinda Sarkar, Ph.D., the corresponding author of the study. The researchers are able to transport the drugs without modifying any of the molecules involved. They say this development will aid in evaluation of potential new drugs for brain cancer.

The blood-brain barrier is meant to protect the brain from numerous undesirable chemicals circulating in the body, but it also obstructs access for treatment of brain tumors and other conditions. Too often the only recourse is invasive, which often limits a drug's effectiveness or causes irreversible damage to an already damaged brain. Nearly all of the drugs that could potentially help are too large to normally pass through the barrier. Additionally, other methods may damage the vascular system.

In this case, the synthetic peptide K16ApoE, once injected into a vein, binds to proteins in the blood to create entities that can pass for near-normal ligands to some receptors present on the blood-brain barrier. The 'pseudo-ligand' receptor interaction creates what the researchers believe to be transient pores through which various molecules can be transported to the brain. The molecules they've transported in this manner include cisplatin, methotrexate, cetuximab, three different dyes, and synthetic peptides Y8 and I-125. The researchers believe this is the least complicated, least expensive and most versatile method for delivering therapeutics to the brain. Previously, the researchers delivered antibodies targeted against amyloid plaques into the brains of mouse models of Alzheimer's disease using this same method.

"We know that some chemotherapeutic agents can kill brain tumor cells when they are outside the brain (as in a laboratory test). But because the agents cannot cross the blood-brain barrier, they are not able to kill brain tumor cells inside the brain. With the peptide carrier, these agents can now get into the brain and potentially kill the tumor cells," says Mayo neurology researcher Robert Jenkins, M.D., Ph.D., senior author of the study.

The researchers say their method, which has been successfully demonstrated in mice, meets three of five requirements for a usable therapy: It's feasible as a repeated procedure; it should be relatively easy to introduce into medical practice; and it would work for any size or location of brain tumor. More research will need to be done to prove effectiveness and determine any adverse effects.


'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
2. First targeted nanomedicine to enter human clinical studies
3. Clinical insight improves treatment with new lung cancer drug
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Mayo Clinic launches whole genome breast cancer study
6. Mayo Clinic offers newly approved treatment for acid reflux disease
7. NYU Langone experts present research, clinical advances at neurosurgeons meeting
8. Mayo Clinic breast cancer study finds new type of mutation
9. Kroenke honored for outstanding contributions in clinical research training
10. Awards celebrate clinical research that can improve health and alleviate suffering
11. Association for Psychological Science, SAGE launch Clinical Psychological Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2020)... HILLS, Calif. (PRWEB) , ... February 13, 2020 , ... ... and cosmetic procedures that people will be discussing in 2020. It also reports on ... cosmetic and surgical procedures. Dr. Jazayeri says that his patients are increasingly knowledgeable and ...
(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... The wait is finally over. The first ... Nordisk. For years, this squad has been associating professional sports to a truly special project. ... the world made up entirely of athletes with diabetes. They decided to take on the ...
(Date:2/10/2020)... ... February 10, 2020 , ... A January 26 article on ... situations. The answer is that – not unlike the skin’s response to dangerous conditions ... serve as an alert to potential damage being done and warn the individual to ...
(Date:2/10/2020)... ... , ... C. A. Shively officially formed The Association of Young Business Owners ... the music business as a majority label stakeholder in Hustle N Flow (HNF) Music ... HNF to create any music compositions needed for AYBOS. No one from AYBOS would ...
(Date:2/10/2020)... ... February 10, 2020 , ... How About That’s Sweet Trail Mix is a blend of keto ... 17 grams of fat, 4 grams of protein and 3 grams of net carbs with ... and sea salt, making it the cleanest keto trail mix on the market. , The ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... LOS ANGELES (PRWEB) , ... February 14, 2020 , ... ... fill, and cooling pillow insert for a relaxing sleep experience—are excited to announce the ... has planned, developed, and shipped four different types of pillows over the last four ...
(Date:2/14/2020)... AUSTIN, Texas (PRWEB) , ... February 14, 2020 ... ... company serving emergency medical services (EMS), fire departments and hospitals, today announced Dr. ... Founder and Chair of Exponential Medicine – will deliver one of three keynote ...
(Date:2/14/2020)... YORK (PRWEB) , ... February 14, 2020 , ... ... a cutting-edge dental practice that conveniently offers a complete range of dental services under ... 2019 Top Patient Rated Dentist by Find Local Doctors . Find Local Doctors ...
Breaking Medicine Technology: